| Schedule of accounts
payable and accrued liabilities |
|
|
|
|
|
|
|
|
| |
|
As of March 31, |
| |
|
2026 |
|
2025 |
| |
|
|
|
|
| Accounts payable |
|
$ |
2,413 |
|
|
$ |
427 |
|
| Accrued other professional fees |
|
|
— |
|
|
|
262 |
|
| Accrued accounting and auditing fees |
|
|
73 |
|
|
|
155 |
|
| Accrued bonuses and other payroll-related expenses |
|
|
913 |
|
|
|
89 |
|
| Accrued CRO |
|
|
— |
|
|
|
80 |
|
| Accrued legal fees |
|
|
414 |
|
|
|
60 |
|
| Accrued clinical and R&D services |
|
|
— |
|
|
|
14 |
|
| Capital expenditures |
|
|
333 |
|
|
|
0 |
|
| Other |
|
|
— |
|
|
|
13 |
|
| Total accounts payable and accrued liabilities |
|
$ |
4,146 |
|
|
$ |
1,100 |
|